AU735113C - Opioid formulations for treating pain - Google Patents

Opioid formulations for treating pain

Info

Publication number
AU735113C
AU735113C AU87145/98A AU8714598A AU735113C AU 735113 C AU735113 C AU 735113C AU 87145/98 A AU87145/98 A AU 87145/98A AU 8714598 A AU8714598 A AU 8714598A AU 735113 C AU735113 C AU 735113C
Authority
AU
Australia
Prior art keywords
treating pain
opioid formulations
opioid
formulations
pain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU87145/98A
Other versions
AU8714598A (en
AU735113B2 (en
Inventor
Paul Goldenheim
Robert Kaiko
Richard Sackler
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MUNDIPHARMA MEDICAL GmbH
Original Assignee
MUNDIPHARMA MEDICAL GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=3703668&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AU735113(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from AU13313/95A external-priority patent/AU693134B2/en
Application filed by MUNDIPHARMA MEDICAL GmbH filed Critical MUNDIPHARMA MEDICAL GmbH
Priority to AU87145/98A priority Critical patent/AU735113C/en
Publication of AU8714598A publication Critical patent/AU8714598A/en
Assigned to MUNDIPHARMA MEDICAL GMBH reassignment MUNDIPHARMA MEDICAL GMBH Alteration of Name(s) of Applicant(s) under S113 Assignors: EURO-CELTIQUE S.A.
Application granted granted Critical
Publication of AU735113B2 publication Critical patent/AU735113B2/en
Publication of AU735113C publication Critical patent/AU735113C/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

AU87145/98A 1991-12-24 1998-09-25 Opioid formulations for treating pain Ceased AU735113C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU87145/98A AU735113C (en) 1991-12-24 1998-09-25 Opioid formulations for treating pain

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US214111 1991-12-24
AU13313/95A AU693134B2 (en) 1991-12-24 1994-11-22 Opioid formulations for treating pain
AU87145/98A AU735113C (en) 1991-12-24 1998-09-25 Opioid formulations for treating pain

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
AU13313/95A Division AU693134B2 (en) 1991-12-24 1994-11-22 Opioid formulations for treating pain

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU46009/01A Division AU4600901A (en) 1991-12-24 2001-05-16 Opioid formulations for treating pain

Publications (3)

Publication Number Publication Date
AU8714598A AU8714598A (en) 1998-12-17
AU735113B2 AU735113B2 (en) 2001-06-28
AU735113C true AU735113C (en) 2007-06-14

Family

ID=3703668

Family Applications (1)

Application Number Title Priority Date Filing Date
AU87145/98A Ceased AU735113C (en) 1991-12-24 1998-09-25 Opioid formulations for treating pain

Country Status (1)

Country Link
AU (1) AU735113C (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU617573B2 (en) * 1989-01-06 1991-11-28 Mayne Pharma International Pty Ltd Sustained release pharmaceutical composition
AU6439394A (en) * 1993-03-30 1994-10-24 Pharmacia Ab Controlled release preparation containing a salt of morphine
AU6610594A (en) * 1991-12-24 1995-01-12 Euro-Celtique S.A. Sustained release compositions and a method of preparing pharmaceutical compositions

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU617573B2 (en) * 1989-01-06 1991-11-28 Mayne Pharma International Pty Ltd Sustained release pharmaceutical composition
AU6610594A (en) * 1991-12-24 1995-01-12 Euro-Celtique S.A. Sustained release compositions and a method of preparing pharmaceutical compositions
AU6439394A (en) * 1993-03-30 1994-10-24 Pharmacia Ab Controlled release preparation containing a salt of morphine

Also Published As

Publication number Publication date
AU8714598A (en) 1998-12-17
AU735113B2 (en) 2001-06-28

Similar Documents

Publication Publication Date Title
GB2274778B (en) Improved transdermal formulations
GB2282325B (en) Preparation for epidermis
AU1966992A (en) Skin treatment system
CZ9300230A3 (en) Compound topic preparations for treating pain
GB9208339D0 (en) Treatment composition
EP0499260A3 (en) Procedure for hydrolyzing keratin
AU1535292A (en) Ozonator apparatus
IL103205A0 (en) Compounds for treating leukotriene-related diseases
AU2312392A (en) Skin treatment device
GB9109007D0 (en) Therapeutic method
IL117670A0 (en) Low dose ridogrel formulations
AU2676192A (en) Treatment devices
GB9315275D0 (en) Formulation for treating silage
GB9411992D0 (en) Preparation for epidermis
AU735113C (en) Opioid formulations for treating pain
GB9117819D0 (en) Therapeutic compounds
AU5419894A (en) Dental treatment aid
NZ243596A (en) Patch for administering bimakalim transdermally
AU1457092A (en) An agent for animal skin treatment
AU2595692A (en) Hair treatment composition
AU1810792A (en) Anti-corrosion treatment
AU2801092A (en) Drugs for treating aids
HK1070295A1 (en) Opiod formulations for treating pain
AU5066293A (en) Treatment device
AU2048592A (en) Seed treatment

Legal Events

Date Code Title Description
PC1 Assignment before grant (sect. 113)

Owner name: MUNDIPHARMA MEDICAL GMBH

Free format text: THE FORMER OWNER WAS: EURO-CELTIQUE S.A.

DA2 Applications for amendment section 104

Free format text: THE NATURE OF THE PROPOSED AMENDMENT IS AS SHOWN IN THE STATEMENT(S) FILED 20010516

CB Opposition lodged by

Opponent name: GRUNENTHAL GMBH

CB4 Opposition under section 104(4) lodged

Opponent name: GRUNENTHAL GMBH

CH4 Opposition under section 104(4) withdrawn

Opponent name: GRUNENTHAL GMBH

ON Decision of a delegate or deputy of the commissioner of patents (result of patent office hearing)

Free format text: THE OPPOSITION TO THE GRANT OF A PATENT HAS BEEN UNSUCCESSFUL ON ALL GROUNDS, COSTS ARE AWARDED AGAINST THE OPPONENT.

Opponent name: GRUNENTHAL GMBH

Effective date: 20061218